SlideShare a Scribd company logo
Analytical QBD in Nutshell
Overview and Case Study….
Agenda
2 What is AQBD ?
3 Case Study
1 Who we are ?
BUSINESS
SOLUTIONS TECHNOWLOGIES
INTERNATIONAL
The SSA Spectrum
Origin:
Founded in 1999 in India by Mr. NC Narayanan
Presence:
Global footprint across 20+ Countries with headquarters in
Mumbai, India
Consulting Landscape:
Business transformation across
hundreds of industries including
• Automobile
• Pharma
• FMCG
• Life Science
• Banking & Finance
• Insurance
• Plastics
• Telecommunication
• Packaging
Contribution To The Industry:
• Groomed over 5000 Business excellence
professionals
• Help transformed 100s of organizations
worldwide
• Enabled industries to provide best in class
products and services
• Contributed to sustainable economic
development
SSA Leadership Team
Ganesh Iyer BE, MBA (INSEAD)
MD SSA Tech
Vijay Dhonde BE,
CEO
Sashi Iyer B.Com, MBA (INSEAD)
MD SSA India
NC BE, MS (Research)
Chairman
Naveen Narayanan
BE, MBA (USA), MSc (UK)
MD SSA Int
SSA’s Pharma Offerings
Pharma
Excellence
R & D
Excellence
QBD / DOE
DFSS / NPI
Lean
CAPA
Investigati
on
Manufacturing
Excellence
Lean Six
Sigma
CAPA
Investigation
Statistical
Analysis
for QA / QC
Select Pharma Clientele
And Many More
China
Srilanka
Pakistan
Bangladesh
Singapore
Indonesia
Malaysia
Thailand
Hong Kong
Philippines
Vietnam
Saudi Arab
Oman
Kenya
South Africa
Nigeria
Ghana
Zimbabwe
Egypt
United Kingdom
INDIA
Internationalization
Differentiators
VALUE
BASED
CONSULTING
TOP
MANAGEMENT
ENGAGEMENT
CONVERTING
STRATEGIES
INTO PROJECT
LEADING
IMPLEMENTATION
INTERNALIZATION
– KNOWLEDGE
TRANSFER
Premium Training & Certification
Lean Six
Sigma
Quality by
Design
DFSSCAPA
Value Stream
Mapping
Problem
Solving Tools
( 7 QC Tools )
Balanced
Scorecard
Publications
Under publication
in Aug 2016
R & D EXCELLENCE
- QUALITY BY DESIGN (QbD)
- NPI LEAN
Analytical Quality By Design
(AQBD) Overview
What is QBD ?
 As per ICH, QbD is defined as
“A systematic approach to development that begins with
predefined objectives and emphasizes product and
process understanding and process control, based on
sound science and quality risk management.”
Analytical Target
Profile (ATP)
identification
Identification includes the selection of method
requirements such as target analytes, analytical
technique category, and product specifications.
Critical Quality
Attributes (CQA)
Identification
Select appropriate analytical technique for
desired measurement. Define method
performance criteria ( critical Quality attributes)
Risk Assessment
using FMECA
Assess risks of method operating parameters
and sample variation.
Method
Development /
Validation using
DOE
Examine potential multi-variate interactions.
Understand method robustness and ruggedness
Establish Control
Strategy
Define control space and system suitability,
meet method performance criteria
Continuous
method
monitoring and
improvement
CMM is final step in AQbD life cycle; it is a
continuous process of sharing knowledge
gained during development and implementation
of design space
AQbD ( Analytical QBD ) Roadmap
What’s Needed
QBD Approach Basics of Statistics
Target
measurement
based on
product QTPP
and CQA
Select
Techniques
for desired
measurement
Risk
Assessment
using FMECA
Method
Development /
Validation
using DOE
Establish
Control
Strategy
Continual
Improvement
Basic Statistics
Definition of Quality
 ISO 9000 Definition of Quality: “Customer satisfaction”
Statistical Definition of Quality:
Q = f (Hitting the Target ,Reducing the variation)
Measures Of Central Tendency
 Numerical value that describes the central position of
the data
 Represent different ways of characterizing the central
value of a collection of data.
 Simply, it is the middle point of a distribution.
 Also called as measures of location
 Three of these measures are:
• Mean
• Median
• Mode
Measures Of Central Tendency
 Let us take the following series :7,23,4,8,3,9,9
7+23+4+8+3+9+9
Mean = = 63/7=9
7
3
4
7
8
9
9
23
Median
middle-most value
Average
Mode most repeated value (2 times)
Curve B
Curve C
Curve A
Mean of A,B,C
Variation
Measures Of Variation
Measures Of Dispersion (Variation)
 It is the spread or variability of the data set.
 Three types of measures of dispersion are
• Range
• Variance and
• Standard Deviation
Range
 It is the difference between the highest and lowest
observed values
 Range = Value of Highest observation - Value of Lowest
observation
Example:
 Let us take the following series
3,6,4,9,5,6,7,1,6,3,2,9,8,6,4,2.
Max Value = 9 Min Value = 1
Range= 9 -1=8
Observations (x1,x2..xn)
n - total no. of observations
Mean ( µ )
( i - observed item)
Deviation di = Xi- µ
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
variable
frequency
d1
d2
d3
d4 d5
Variance And Standard Deviation
Null Hypothesis (H0) :
The hypothesis to be tested, usually an assumption of
status quo (equality, i.e.. no difference).
No Significant impact on CQA / Response ( P > 0.050 )
Alternate Hypothesis (Ha) :
The condition of equality assumed in the Null hypothesis is
not true.
There is a Significant impact on CQA / Response( P < 0.05)
USE ANOVA ( Analysis of Variance ) for analysis
Types of Hypothesis
Hypothesis Testing
 Statistical Hypothesis:
There is no difference
between the old machines
and the improved one.
 This is called the Null
Hypothesis (Ho)
• Real Life Hypothesis: The
newly modified machine will
reduce defects.
• This is called the Alternative
Hypothesis (Ha)
Ho:
Ha:
a
a
m m
m m
=
<
b
b
• We must show that the values we observed were so unlikely to come
from the same process, that Ho must be wrong.
X (Input)
y (Output)
• Tells the relationship between the
two variables X and Y
• X is the input variable on
x(horizontal)-axis
• Y is the output variable on the
Y(vertical)-axis
Use R-Sq Value for Model
Significance
Correlation & Regression Analysis
Project Case Study
Project Scenario
To optimise Related Substance Method that is Specific, Selective,
Reproducible and Robust and is acceptable to the plant and
regulatory agencies. This project is due for technology transfer at the
manufacturing location.
• To develop the robust and reproducible method for the quantification
of Unknown impurity eluting at the tail of XYZ Peak with USP
Resolution of NLT 3.5 between main peak and unknown impurity
along with resolution of all other known impurities.
– Resolution
– Retention time
Analytical Target Profile (ATP)
• General ATP for analytical procedures is as follows:
– Target analytes selection (API and impurities)
• ICH Q3 and all other regulatory guidance explained the consideration of impurities in
the API synthetic route
– Technique selection (HPLC, GC, HPTLC, Ion Chromatography, chiral
HPLC, etc.)
• Analytical test item and purpose of test are also important for selecting the technique
– Method requirements selection (assay or impurity profile or residual
solvents)
• Method requirements can vary from one method to another. The common ATPs for
impurity profile by HPLC method
Critical Quality Attributes (CQA)
CQA for analytical methods includes method attributes and method
parameters. Each analytical technique has different CQA.
• HPLC (UV or RID) CQA are mobile phase buffer, pH, diluent, column
selection, organic modifier, and elution method.
• GC methods CQA are gas flow, oven temperature and program,
injection temperature, sample diluent, and concentration.
• HPTLC method CQA are TLC plate, mobile phase, injection
concentration and volume, plate development time, color development
reagent, and detection method
Note : Nature of impurities and DS can define the CQA
for analytical method development such as solubility, pH
value, polarity, charged functional groups, boiling point,
and solution stability
QUALITATIVE RISK
ASSESSMENT
Mapping the Linkage : Method
attributes and Method Parameters
M1
M2
Method Attributes
P1
P2
Method
Parameters
P3
CQA1
CQA2
Critical
Quality
Attributes
CQA3
P2 might not be needed in
the establishment of Design
Space
Source: CDER & FDA
Purpose:
Understand & Control the variability of
Method Attributes & Critical method
Parameters to meet CQA’s
Qualitative Risk Assessment Criteria
Red Color High Risks
Risks that need to be addressed by actual
studies to establish acceptable ranges
Yellow Color Medium Risks
Possibility for a change in factor level to affect
method robustness but small variations in this
factor do not adversely affect pharmaceutical
quality
Green Color Low risks Factors having wide range of acceptability
• Risk estimation helps to identify what to study as a part of analytical
method development
• Evaluation of qualitative risk is ultimately linked back to potential harm to
the patient
Qualitative Risk Assessment : Prioritization Matrix
Attributes Resolution Justification
Column type Kept constant
Column make Kept constant
Particle size of the column has impact on Resolution
Column length has impact on Resolution
% Carbon loading
Column make is constant so %
Carbon loading is constant
Internal diameter of column Kept constant
Mobile phase buffer
Kept constant (potassium
dihydrogen phosphate)
Modifier used in Buffer and its qty has impact on Resolution
Mobile phase composition
has impact on Resolution as polarity
of solvents are diff
System make No impact on resolution
Detector sensitivity (UV/PDA)
This impacts the Limit of detection
and quantitation but will have no
impact on resolution
Qualitative Risk Assessment : Prioritization Matrix
Attributes Resolution Justification
UV Lamp hours
This impacts the Limit of detection
and quantitation but will have no
impact on resolution
Type of elution (Gradient/ Isocratic) Kept constant (Gradient)
Make of reagents Kept constant
Different lots of Drug Product tested Kept constant
Analyst Constant
Column temperature
Column temperature influences the
resolution between peaks
Flow rate of system
Flow rate changes the retention time
but this may or may not impact
resolution
pH of the mobile phase buffer
Has impact on Resolution as different
peaks will have different retention
time at diff pH due to their pKa values
Detection wavelength Kept constant at 240 nm
Lot number of the column Kept constant
Sample preparation technique
(Intact/crushed) Kept constant
Organic used in Mobile phase
has impact on Resolution as polarity
of solvents are diff
QUANTITATIVE RISK
ASSESSMENT
FMECA – Identify critical factors
 To study the critical factors, the team conducted a risk
assessment using a FMECA.
 Output from the risk assessment study was based on
risk score which was used to identify the critical factors
required for the study
 Risk priority scores included an estimate for
detectability, severity and probability
Severity Scores Rating
Score Severity Description of impact on patient if failure to meet acceptance
criteria
1 Minor No impact on patient
2 Major Some impact on product, but reversible
3 Critical Impact on product but not product life threatening (rejection)
4 Catastrophic High impact on product which is irreversible and potentially
wastage
Probability Scores Rating
Score Probability of not meeting
acceptance
Comment
1 Extremely low Extremely low chance of occurring, never
seen
2 Low Low chance of occurring, but could happen
3 Medium Will happen
4 High High occurrence of failure
Detectability Scores Rating
Score Detectability
scores
Comment
1 Very high Failure can be detected in unit operation
2 High Failure can be detected after unit operation and before end
product testing
3 Low Will happen
4 None High occurrence of failure
Risk Score
Risk priority number range Risk rating
1 to 17 Low
18 to 35 Medium
36 to 64 High
RPN scores were grouped into high, medium, and low risk. The boundaries
for differentiation between high, medium, and low were established by the
risk assessment team for this exercise.
Quantitative Risk Assessment: FMECA
Process
Parameter or
Material Attribute
Effect/ Suggested contingency/
Comment
Probability
(P)
Severity
(S)
Control
(C) RPN
Risk
Rating
Column
temperature Justification 4 3 2 24 Medium
Flow rate of
system To be studied 2 2 2 8 Low
Detector
sensitivity
(UV/PDA) To be kept constant at 1 mL/minute 2 2 1 4 Low
Column make Kept Constant UV Detector of All-15 4 2 1 8 Low
Particle size of
the column
based on earlier expts the make
giving best resolution is selected and
is kept constant 4 4 3 48 High
Mobile phase
composition
(aqueous and
organic)
To be studied for the impact of change
in micron over resolution 4 4 3 48 High
Modifier used in
Buffer and its qty
decided to keep the composition as
constant and vary the type of organic
(Gradient program is constant) 3 3 2 18 Medium
Type of organic
used in Mobile
phase In this case no modifier used 4 4 3 48 High
pH of the mobile
phase buffer to be studied for ACN and methanol 4 4 3 48 High
Column length To be studied 4 4 3 48 High
Response ( CQA )
Response Unit Target Comment
Resolution Numbers NLT 3.5
Retention time Mins NMT 75
Analysis needs to be
completed before 75 mins
else the impurity is not
detected
Experimental Factors
Experimental Factor Unit
Low
Level
High
Level
Comments/ Remarks
Column temperature deg C 25 45
Currently selected column temperature
is 30 deg C and lower range selected at
room temp and higher range at 45 deg
is within the cut off temperature of 60
deg C
Particle size of the column micron 3 5
Particle size impacts separation, lower
& higher values selected based on the
availability
Column length cm 150 250
Column length impacts separation,
lower & higher values selected based
on the availability
Acetonitrial % 50 100
100% Methanol not selected as this
may increase the back pressure and
may go beyond operating range for 3µ
column
pH of the mobile phase buffer 2 7
Current pH of the mobile phase is 3.5
and range is selected based on the
optimum operating range of the column
Constant Factors
Constant Factors Unit Level
System make HPLC Alliance -15
UV Lamp hours Hours
Same instrument will be used so
this will remain constant
throughout
Calibration of the HPLC Yes
Calibrated instrument will be
used
Volume of Mobile phase prepared mL
1000 mL (same qty of mobile
phase will be prepared each set)
Analyst Sandeep Gawas
% Carbon loading 15%
Age of the column
New Column will be used for
study and same will be used for
all expt except for the change in
column
Column type Inertsil ODS 3 L1
Different lots of Drug Product tested Batch No. A-12
Internal diameter of column mm 4.6 mm
Lot number of the column
Make of reagents AR Grade
Merck and same Lot No. from
one bottle will be used
Water Quality HPLC Grade TKA of fourth floor
Age of the sample
3 Month old
sample CRT sample
Constant Factors
Constant Factors Unit Level
Column Equilibriation time Hour 1 Hour before the injection acquisition
Detection wavelength nm Fixed at 240 nm
Injection volume µL Fixed at 20µL
Type of elution (Gradient/ Isocratic) Gradient program fixed
Previous use of the column (Product/washing solvent) New column to be used for the expt
Mobile phase buffer
potassium dihydrogen orthophosphate
1.36 gm/L
Type of filter used for Mobile Phase filtration Millipore 0.45 µ
Order of addition of diluent Fixed as per STP
Sample concentration ppm Fixed at 600 ppm as per STP
Sample preparation technique (Intact/crushed)
Crushed Method to be followed as per
STP
Sample solution stability Days
Same Sample preparation to be used
for 8 Days
Sampling (Representative sample)
Sample to be used from single
container at the start of expt
Room temperature and Humidity
deg C & %
RH 25+/- 5 deg and 65+/-5% RH
Storage of the samples In Laboratory
pH meter A197
Balance used A200
Cylinder used for Volume measurement Class A
Same Cylinder to be used through out
the expt
Sonnicator A199
Sample preparation Filter 0.45 µ Make MDI, discard volume 1 mL
Design Selection Matrix
Parameter Fractional Factorial Half Fraction Full Factorial Mixture RSM
Type of
design Screening Basic Basic
Basic +
Optimization Optimization
No. of
Responses 1-2 1-2 1-3 2-3 2 or more
Factors More than 5 4-5 3-4 3-4 3-4
Expected
outcome
• Identify significant
factors with main
effect only
• Eliminate
insignificant factors
for next level of
experiment
• Identify the
main effects &
interaction
effect
• Get prediction
equation
• Curvature with
1 center point
• Identify the
main effects &
interaction
effect
• Get prediction
equation
• Curvature with
1 center point
• Identify design
space
• Identify the
main effects &
interaction
effect
• Optimum
proportion for
mixture
• Get prediction
equation
• Identify design
space
• Identify right
factor settings
for optimum
operation
• Identify design
space
Pre-requisite
None None • None
•Composition
type
•Quantitative
All should be
quantitative
Additional
elements
None
• Include center
point to check
curvature
• Include center
point to check
curvature
• Augmentation
done to get
precise results • None
Screening Design : Resolution V
Std
Order
Run
Order
Center
Pt Block
Column
temp
Particle
Size
%
Acetonitrile
Column
Length
pH of
MP Resolution
Retention
Time
11 1 1 2 25 5 50 150 7 6.20 75.626
9 2 1 2 25 3 50 250 7 9.60 58.120
10 3 1 2 45 3 50 150 2 2.93 71.112
12 4 1 2 45 5 50 250 2 3.25 72.119
15 5 1 2 25 5 100 150 2 2.91 62.875
14 6 1 2 45 3 100 150 7 7.57 58.276
13 7 1 2 25 3 100 250 2 3.48 49.501
16 8 1 2 45 5 100 250 7 6.92 57.980
2 9 1 1 45 3 50 150 2 2.88 58.243
6 10 1 1 45 3 100 150 7 6.79 49.321
8 11 1 1 45 5 100 250 7 6.35 62.924
3 12 1 1 25 5 50 150 7 6.44 70.626
7 14 1 1 25 5 100 150 2 2.80 58.150
4 15 1 1 45 5 50 250 2 3.09 75.721
5 16 1 1 25 3 100 250 2 3.35 72.035
Residual Analysis : Sanity check of
Experimental Trials
As seen from the residual above, the residuals are normally distributed, with
random variation and within the limits of +/-2%. Hence, it can be
concluded that the experimental error is minimum
Initial results For Resolution: ANOVA
R-Sq = 99.59% R-Sq(pred) = 97.87% R-Sq(adj) = 99.13%
Analysis of Variance for Resolution (coded units)
Source DF Seq SS Adj SS Adj MS F P
Blocks 1 0.2233 0.2233 0.2233 4.40 0.074
Main Effects 5 82.868 82.868 16.5736 326.63 0.000
Column temperatu 1 1.1396 1.1396 1.1396 22.46 0.002
Particle size of 1 3.9105 3.9105 3.9105 77.07 0.000
%Acetonitrile 1 0.7613 0.7613 0.7613 15.00 0.006
Column length 1 2.8815 2.8815 2.8815 56.79 0.000
pH of the mobile 1 74.1752 74.1752 74.1752 1461.81 0.000
2-Way Interactions 2 3.5921 3.5921 1.796 35.40 0.000
Particle size of the
column*%Acetonitrile
1 0.7613 0.7613 0.7613 15.00 0.006
Particle size of the column*pH
of the mobile phase buffer
1 2.8308 2.8308 2.8308 55.79 0.000
Residual Error 7 0.3552 0.3552 0.0507
Total 15 87.0385 0.2233 0.2233
P Value for Linear , Interaction term is less
than 0.05 hence very significant
R-Sq = 99.99% R-Sq(pred) = 99.95% R-Sq(adj) = 99.98%
Analysis of Variance for Retention Time (coded units)
Source DF Seq SS Adj SS Adj MS
Blocks 1 0.03 0.026 0.076
Main Effects 4 1049.66 880.170 220.043
Column temperature 1 104.15 214.096 214.096
Particle size of the column 1 131.45 8.492 8.492
%Acetonitrile 1 195.16 307.751 307.751
Column length 1 618.90 500.927 500.927
2-Way Interactions 1 10.37 10.373 10.373
Particle size of the column*%Acetonitrile 1 10.37 10.373 10.373
Residual Error 7 0.14 0.140 0.020
Total 13 1060.20
Source F P
Blocks 1.33 0.287
Main Effects 11040.61 0.000
Column temperature 10742.26 0.000
Particle size of the column 426.08 0.000
%Acetonitrile 15441.38 0.000
Column length 25133.95 0.000
2-Way Interactions 520.45 0.000
Particle size of the column*%Acetonitrile 520.45 0.000
Residual Error
Total
Initial Result For Retention Time: ANOVA
P Value for Linear , Interaction term is less
than 0.05 hence very significant
Why RSM
 Most surfaces are flatter further away from optimal settings.
• Use linear models when we are far from the optimums.
• Use quadratics to approximate the surfaces near the peaks
Curved line represents the response better as compared to the straight line
R00 0512
 Response Surface Methodology uses a quadratic
model (that includes the squared term).
 For one X the equation is:
 This model produces parabolas such as:
The Quadratic Model : Curvature
2
1 2y a b x b x=  
Result Summary for Resolution and Retention Time
• Based on the results for Resolution & Retention Time and considering
that no terms have been dropped for Resolution, it was decided to
add 2 more trials with centre point setting. It would help in
analysing the response better as well and identify the curvature if
present in the design. Since column length is a discrete factor and in
future it would be advisable to use the column length at 150, it was
decided to set it as constant. Also, based on team’s domain
knowledge and expertise particle size was set at 5 micron.
• Settings for centre points run are:
– Column Length – 150 (constant)
– Particle Size – 5 micron (constant)
– pH of mobile phase – 4.5 (center)
– Column temperature – 35 Deg (center)
– % Acetronitrile – 75% (center
Experiments with Centre Points
Std
Order
Run
Order
Center
Pt
Bloc
k
Colum
n temp
Particl
e Size
%
Acetonitril
e
Column
Length
pH of
MP Resolution
Retentio
n Time
11 1 1 2 25 5 50 150 7 6.20 75.626
9 2 1 2 25 3 50 250 7 9.60 58.120
10 3 1 2 45 3 50 150 2 2.93 71.112
12 4 1 2 45 5 50 250 2 3.25 72.119
15 5 1 2 25 5 100 150 2 2.91 62.875
14 6 1 2 45 3 100 150 7 7.57 58.276
13 7 1 2 25 3 100 250 2 3.48 49.501
16 8 1 2 45 5 100 250 7 6.92 57.980
2 9 1 1 45 3 50 150 2 2.88 58.243
6 10 1 1 45 3 100 150 7 6.79 49.321
8 11 1 1 45 5 100 250 7 6.35 62.924
3 12 1 1 25 5 50 150 7 6.44 70.626
7 14 1 1 25 5 100 150 2 2.80 58.150
4 15 1 1 45 5 50 250 2 3.09 75.721
5 16 1 1 25 3 100 250 2 3.35 72.035
17 17 0 1 35 5 75 150 4.5 2.70 57.980
18 18 0 1 35 5 75 150 4.5 2.60 56.900
Resolution analysis with centre point :Anova
Analysis: Resolution
Figure below shows the results of centre point analysis conducted on the experiment results for Resolution
R-Sq = 96.01% R-Sq(pred) = 78.73% R-Sq(adj) = 93.21%
Analysis of Variance for Resolution (coded units)
Source DF Seq SS Adj SS Adj MS F P
Blocks 1 2.3717 0.2233 0.2233 0.56 0.470
Main Effects 5 89.4256 82.8680 16.5736 41.93 0.000
Column temperature 1 1.1396 1.1396 1.1396 2.88 0.120
Particle size of the column 1 7.9974 3.9105 3.9105 9.89 0.010
%Acetonitrile 1 0.7613 0.7613 0.7613 1.93 0.195
Column length 1 5.3522 2.8815 2.8815 7.29 0.022
pH of the mobile phase buffer 1 74.1752 74.1752 74.1752 187.68 0.000
Curvature 1 3.2137 3.2137 3.2137 8.13 0.017
Residual Error 10 3.9523 3.9523 0.3952
Lack of Fit 9 3.9473 3.9473 0.4386 87.72 0.083
Pure Error 1 0.0050 0.0050 0.0050
Total 17 98.9632
Prioritized Terms for Resolution
Based on the results from the above analysis, it can be clearly seen that:
 Curvature effect is present which urges for a RSM model to predict the
response
 The factors identified as significant are: pH of mobile phase, Particle size,
and Column length
Analysis: Retention Time
S = 1.04461 PRESS = 45.2842
R-Sq = 99.23% R-Sq(pred) = 96.01% R-Sq(adj) = 98.56%
Analysis of Variance for rt of Imp A (coded units)
Source DF Seq SS Adj SS Adj MS F P
Blocks 1 9.02 0.03 0.026 0.02 0.880
Main Effects 5 1110.61 1052.03 210.406 192.82 0.000
Column temperature 1 96.22 263.03 263.032 241.04 0.000
Particle size of the column 1 75.81 1.76 1.763 1.62 0.239
%Acetonitrile 1 195.16 365.92 365.922 335.33 0.000
Column length 1 740.11 574.45 574.448 526.43 0.000
pH of the mobile phase buffer 1 3.31 2.37 2.366 2.17 0.179
Curvature 1 5.54 5.54 5.537 5.07 0.054
Residual Error 8 8.73 8.73 1.091
Lack of Fit 7 8.15 8.15 1.164 2.00 0.498
Pure Error 1 0.58 0.58 0.583
Total 15 1133.89
Retention Time with centre point :Anova
Particle size of the column
pH of the mobile phase buffer
Column temperature
%Acetonitrile
Column length
2520151050
Term
Standardized Effect
2.31
Pareto Chart of the Standardized Effects
(response is rt of Imp A, Alpha = 0.05)
Based on the results from the above ANOVA table and Pareto Chart, we can conclude
 Curvature effect is present for this response
 The factors identified as significant are: Column length, % Acetonitrile, and
Column temperature
Prioritized Terms for Retention Time
Significant Factors
• Out of the five factors selected for the screening design, the factors
that are significant are:
• After discussion and analysis with the team, it was decided that the
following factors will be selected for optimization design:
– Column length (Experimental): Axial Low (150), Axial High (250)
– Column Temperature: Axial Low (25), Axial High (45)
– pH: Axial Low (2), Axial High (7)
– %ACN: Axial Low (100), Axial High (100)
– Particle Size (Constant): 5 micron
• A 30 trial Central Composite design has been suggested for
optimization
Response 1 - Resolution Response 2 – Retention time
pH Column temperature
particle size %ACN
column length Column length
Optimized RSM Design
Std Run Type Col Temp %ACN pH Column Length Resolution Retention Time
1 8 Factorial 29 60 3.0 150 2.57 65.572
2 18 Factorial 41 60 3.0 150 2.55 58.917
3 27 Factorial 29 90 3.0 150 2.51 58.510
4 9 Factorial 41 90 3.0 150 2.42 53.262
5 2 Factorial 29 60 6.0 150 3.60 65.751
6 28 Factorial 41 60 6.0 150 4.42 59.190
7 4 Factorial 29 90 6.0 150 3.79 58.690
8 13 Factorial 41 90 6.0 150 3.94 53.067
9 25 Axial 25 75 4.5 150 2.55 64.070
10 19 Axial 45 75 4.5 150 2.57 54.288
11 26 Axial 35 50 4.5 150 2.54 64.877
12 29 Axial 35 100 4.5 150 2.49 53.880
13 15 Axial 35 75 2.0 150 4.95 58.822
14 6 Axial 35 75 7.0 150 5.27 58.718
15 12 Center 35 75 4.5 150 2.48 58.849
17 17 Factorial 41 60 3.0 250 3.07 74.916
18 22 Factorial 29 90 3.0 250 3.13 73.542
19 3 Factorial 41 90 3.0 250 3.03 66.358
21 16 Factorial 41 60 6.0 250 6.02 75.060
22 20 Factorial 29 90 6.0 250 4.02 73.522
23 5 Factorial 41 90 6.0 250 5.62 66.799
24 1 Axial 25 75 4.5 250 3.11 82.293
25 24 Axial 45 75 4.5 250 3.08 67.955
27 7 Axial 35 100 4.5 250 3.20 67.102
28 30 Axial 35 75 2.0 250 3.29 74.211
29 23 Axial 35 75 7.0 250 6.29 74.483
30 14 Center 35 75 4.5 250 2.24 74.311
Final Model for Resolution : ANOVA
Reduced Model (Resolution)
S = 0.453124 PRESS = 9.91394
R-Sq = 88.33% R-Sq(pred) = 74.40% R-Sq(adj) = 84.62%
Analysis of Variance for Resolution
Source DF Seq SS Adj SS Adj MS F P
Regression 7 34.2053 34.2053 4.8865 23.80 0.000
Linear 4 17.0199 17.0199 4.2550 20.72 0.000
Col Temp 1 0.4272 0.4272 0.4272 2.08 0.163
%ACN 1 0.1285 0.1285 0.1285 0.63 0.437
pH 1 13.9586 13.9586 13.9586 67.98 0.000
Column Length 1 2.5056 2.5056 2.5056 12.20 0.002
Square 1 14.4146 14.4146 14.4146 70.20 0.000
pH*pH 1 14.4146 14.4146 14.4146 70.20 0.000
Interaction 2 2.7707 2.7707 1.3854 6.75 0.005
Col Temp*pH 1 0.9702 0.9702 0.9702 4.73 0.041
pH*Column Length 1 1.8005 1.8005 1.8005 8.77 0.007
Residual Error 22 4.5171 4.5171 0.2053
Total 29 38.7223
Resolution : Model Interpretation
As per the ANOVA table above, it can be seen
that:
– The squared term pH is significant for resolution
– There is an interaction between Column temp & pH,
and Column length & pH
– The R-Sq values are 88.83% which determines that the
model is good for prediction of the response
Reduced Model (Retention Time)
S = 0.221488 PRESS = 3.08824
R-Sq = 99.95% R-Sq(pred) = 99.82% R-Sq(adj) = 99.93%
Analysis of Variance for Retention Time
Source DF Seq SS Adj SS Adj MS F P
Regression 9 1711.39 1711.39 190.15 3876.21 0.000
Linear 4 1697.67 1351.38 337.84 6886.80 0.000
Col Temp 1 136.47 277.18 277.18 5650.10 0.000
%ACN 1 98.11 245.63 245.63 5007.11 0.000
pH 1 0.07 0.07 0.07 1.33 0.264
Column Length 1 1463.02 1273.40 1273.40 25957.74 0.000
Square 2 1.04 1.15 0.58 11.75 0.001
Col Temp*Col Temp 1 0.98 0.81 0.81 16.54 0.001
%ACN*%ACN 1 0.06 0.70 0.70 14.32 0.001
Interaction 3 12.68 12.68 4.23 86.17 0.000
Col Temp*%ACN 1 0.04 2.02 2.02 41.19 0.000
Col Temp*Column Length 1 4.15 7.35 7.35 149.86 0.000
%ACN*Column Length 1 8.49 8.49 8.49 173.02 0.000
Residual Error 17 0.83 0.83 0.05
Total 26 1712.22
Final Model for Retention Time : ANOVA
As seen from the ANOVA tables above, it can be
concluded that:
– There is a squared effect of Column Temperature and %
Acetonitrile on the response
– Interaction exists between Column Temperature & %ACN,
Column Temp & Column Length, and %ACN & Column
Length
– Also, the R-Sq value of the reduced model is 99.95% which
is in indicator that the predictability of the model will be
very good
Retention Time : Model Interpretation
Optimum Settings For Validation
• Parameters
Goal Lower Target Upper
• Resolution Maximum 4 6 6
• Retention Ti Minimum 55 55 75
• Optimum settings
– Col Temp = 45
– %ACN = 100
– pH = 6.6
– Column Lengt = 150
• Predicted Responses
– Resolution = 5.0123
– Retention Ti = 52.2091
Optimization Settings
Cur
High
Low0.71144
D
New
d = 0.50614
Maximum
Resoluti
y = 5.0123
d = 1.0000
Minimum
Retentio
y = 52.2091
0.71144
Desirability
Composite
150.0
250.0
2.0
7.0
50.0
100.0
25.0
45.0
%ACN pH Column LCol Temp
[40.0] [100.0] [6.60] [150.0]
Validation Trials
• Validation runs were conducted to test the settings identified using
DOE. The results after validation run were as follows:
Date Analyst LNB Ref Resolution
Rt of
Impurity A
30-12-2013 Sandeep SL1030-71 5.32 59.733
01-01-2014 Varsha SL1030-73 5.52 59.781
02-01-2014 Varsha SL1030-75 5.60 59.849
Design Space
• The desired profile for both the responses are:
– Response Goal Lower Target Upper
– Resolution Maximum 4 6 6
– Retention Ti Minimum 55 55 75
Design Space
• Based on the above desired response values, the design space is
identified as below
Design Space
Design Space
The design space for both the parameters (highlighted in yellow in the above figure) has been identified which is
as given below
 %ACN – 50 to 70
 Column length – 150 constant as it is a discrete factor
 Column temperature – 35 to 45
 pH value – 6.2 to 6.8
THANK YOU

More Related Content

What's hot

Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
Bholakant raut
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
sonia nazir
 
Water system validation
Water system validationWater system validation
Water system validation
Malla Reddy College of Pharmacy
 
qualification of lcms
qualification of lcmsqualification of lcms
qualification of lcms
Ankush Sule
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
SathiyaThaarani
 
ValidationMasterPlan
ValidationMasterPlanValidationMasterPlan
ValidationMasterPlan
PinalPatel248485
 
Process Design to Process Validation
Process Design to Process Validation Process Design to Process Validation
Process Design to Process Validation
Almas Altaf R.Ph
 
Validation master plan
Validation master planValidation master plan
Validation master plan
Dr. Amsavel A
 
Case study on Out of Specification (OOS).
Case study on Out of Specification (OOS).Case study on Out of Specification (OOS).
Case study on Out of Specification (OOS).
Raghavendra institute of pharmaceutical education and research .
 
Method development
Method developmentMethod development
Method development
Gamal Abdel Hamid
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbD
Sneha Kadu
 
Cleaning validation
Cleaning validationCleaning validation
Change control
Change controlChange control
Change control
Syeda Abeer
 
Process validation
Process validationProcess validation
Process validation
Saravanan subramaniyam
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
Vinay Jain
 
Validation master plan
Validation master planValidation master plan
Validation master plan
PARITALA JAGADEESH
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
Devipriya Viswambharan
 
Pharmaceutical process validation.pptx
Pharmaceutical process validation.pptxPharmaceutical process validation.pptx
Pharmaceutical process validation.pptx
Pharmacy
 
Analytical method transfer
Analytical method transferAnalytical method transfer
Analytical method transfer
RamedanHasen
 
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ABG
 

What's hot (20)

Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
 
Water system validation
Water system validationWater system validation
Water system validation
 
qualification of lcms
qualification of lcmsqualification of lcms
qualification of lcms
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
 
ValidationMasterPlan
ValidationMasterPlanValidationMasterPlan
ValidationMasterPlan
 
Process Design to Process Validation
Process Design to Process Validation Process Design to Process Validation
Process Design to Process Validation
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Case study on Out of Specification (OOS).
Case study on Out of Specification (OOS).Case study on Out of Specification (OOS).
Case study on Out of Specification (OOS).
 
Method development
Method developmentMethod development
Method development
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbD
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Change control
Change controlChange control
Change control
 
Process validation
Process validationProcess validation
Process validation
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Pharmaceutical process validation.pptx
Pharmaceutical process validation.pptxPharmaceutical process validation.pptx
Pharmaceutical process validation.pptx
 
Analytical method transfer
Analytical method transferAnalytical method transfer
Analytical method transfer
 
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
 

Viewers also liked

Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by design
Annalisa Forlenza
 
Cii Delhi Naveen
Cii Delhi NaveenCii Delhi Naveen
Cii Delhi Naveen
naveen_ncn
 
Evolution of pharma industry and related opportunities
Evolution of pharma industry and related opportunitiesEvolution of pharma industry and related opportunities
Evolution of pharma industry and related opportunities
BioValley Basel
 
Six sigma and pharmaceutical industry4
Six sigma and pharmaceutical industry4Six sigma and pharmaceutical industry4
Six sigma and pharmaceutical industry4
DrAbdulaziz Saddique
 
Strategic Project Selection in Oil &amp; Gas Industry
Strategic Project Selection in Oil &amp; Gas IndustryStrategic Project Selection in Oil &amp; Gas Industry
Strategic Project Selection in Oil &amp; Gas Industry
naveen_ncn
 
Ich – quality guidelines
Ich – quality guidelinesIch – quality guidelines
Ich – quality guidelines
Harishankar Sahu
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
Sagar Savale
 
Risk management using FMEA in pharma
Risk management using FMEA in pharmaRisk management using FMEA in pharma
Risk management using FMEA in pharma
Sandeep Naik
 
Quality by Design : Design of experiments
Quality by Design : Design of experimentsQuality by Design : Design of experiments
Quality by Design : Design of experiments
GMP EDUCATION : Not for Profit Organization
 
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Karthikeyan Kannappan
 
Healthcare Quality Concepts
Healthcare Quality ConceptsHealthcare Quality Concepts
Healthcare Quality Concepts
alberpaules
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
Naveen Kumar
 
Basic Six Sigma Presentation
Basic Six Sigma PresentationBasic Six Sigma Presentation
Basic Six Sigma Presentation
vivekissar
 
C02
C02C02
C02
grane09
 
Emergency Department Quality Improvement
Emergency Department Quality ImprovementEmergency Department Quality Improvement
Emergency Department Quality Improvement
DrAbdulaziz Saddique
 

Viewers also liked (15)

Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by design
 
Cii Delhi Naveen
Cii Delhi NaveenCii Delhi Naveen
Cii Delhi Naveen
 
Evolution of pharma industry and related opportunities
Evolution of pharma industry and related opportunitiesEvolution of pharma industry and related opportunities
Evolution of pharma industry and related opportunities
 
Six sigma and pharmaceutical industry4
Six sigma and pharmaceutical industry4Six sigma and pharmaceutical industry4
Six sigma and pharmaceutical industry4
 
Strategic Project Selection in Oil &amp; Gas Industry
Strategic Project Selection in Oil &amp; Gas IndustryStrategic Project Selection in Oil &amp; Gas Industry
Strategic Project Selection in Oil &amp; Gas Industry
 
Ich – quality guidelines
Ich – quality guidelinesIch – quality guidelines
Ich – quality guidelines
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Risk management using FMEA in pharma
Risk management using FMEA in pharmaRisk management using FMEA in pharma
Risk management using FMEA in pharma
 
Quality by Design : Design of experiments
Quality by Design : Design of experimentsQuality by Design : Design of experiments
Quality by Design : Design of experiments
 
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
Application of Design of Experiments (DOE) using Dr.Taguchi -Orthogonal Array...
 
Healthcare Quality Concepts
Healthcare Quality ConceptsHealthcare Quality Concepts
Healthcare Quality Concepts
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
Basic Six Sigma Presentation
Basic Six Sigma PresentationBasic Six Sigma Presentation
Basic Six Sigma Presentation
 
C02
C02C02
C02
 
Emergency Department Quality Improvement
Emergency Department Quality ImprovementEmergency Department Quality Improvement
Emergency Department Quality Improvement
 

Similar to Analytical QBD -CPHI 25-27 July R00

Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle management
Chandra Prakash Singh
 
Life cycle of analytical method
Life cycle of analytical methodLife cycle of analytical method
Life cycle of analytical method
Dr. Nandan Dhir Ph.D.
 
1ST REVIEW
1ST REVIEW1ST REVIEW
1ST REVIEW
chandu chatla
 
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
Md. Mizanur Rahman Miajee
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbD
Sneha Kadu
 
QbD and PAT Presentation
QbD and PAT PresentationQbD and PAT Presentation
QbD and PAT Presentation
sunp994
 
AMV final 20Jun17
AMV final 20Jun17AMV final 20Jun17
AMV final 20Jun17
Stephan O. Krause, PhD
 
Phase Appropriate Method Validation Aryo Boston-Nitto 2
Phase Appropriate Method Validation Aryo Boston-Nitto 2Phase Appropriate Method Validation Aryo Boston-Nitto 2
Phase Appropriate Method Validation Aryo Boston-Nitto 2
Aryo Nikopour
 
Analytical Method Validations & Detailed Method Validation Parameters
Analytical Method Validations & Detailed Method Validation ParametersAnalytical Method Validations & Detailed Method Validation Parameters
Analytical Method Validations & Detailed Method Validation Parameters
BussaSravanKumar
 
JPBA published-a platform aQbD approach for multiple methods development
JPBA published-a platform aQbD approach for multiple methods developmentJPBA published-a platform aQbD approach for multiple methods development
JPBA published-a platform aQbD approach for multiple methods development
Jianmei Kochling
 
App. Of Stat. Tools
App. Of Stat. ToolsApp. Of Stat. Tools
App. Of Stat. Tools
Denny Thayil
 
Points to Consider in QC Method Validation and Transfer for Biological Products
Points to Consider in QC Method Validation and Transfer for Biological ProductsPoints to Consider in QC Method Validation and Transfer for Biological Products
Points to Consider in QC Method Validation and Transfer for Biological Products
Weijun Li
 
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Gabor Szabo, CQE
 
ISPE 2011 presentation Dagmar Meissner - 13Jan2011
ISPE 2011 presentation Dagmar Meissner - 13Jan2011ISPE 2011 presentation Dagmar Meissner - 13Jan2011
ISPE 2011 presentation Dagmar Meissner - 13Jan2011
Dagmar Meissner
 
Quality assurance part_2
Quality assurance part_2Quality assurance part_2
Quality assurance part_2
ThorikulHuda2
 
QM-026-Quality Management
QM-026-Quality ManagementQM-026-Quality Management
QM-026-Quality Management
handbook
 
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Aamir Ijaz Brig
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
MANIKANDAN V
 
Process improvment
Process improvmentProcess improvment
Process improvment
jdyjdo
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
roshankhetade2
 

Similar to Analytical QBD -CPHI 25-27 July R00 (20)

Analytical procedures life cycle management
Analytical procedures life cycle managementAnalytical procedures life cycle management
Analytical procedures life cycle management
 
Life cycle of analytical method
Life cycle of analytical methodLife cycle of analytical method
Life cycle of analytical method
 
1ST REVIEW
1ST REVIEW1ST REVIEW
1ST REVIEW
 
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
Analytical method- Content, Development, validation, Transfer & Life Cycle Ma...
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbD
 
QbD and PAT Presentation
QbD and PAT PresentationQbD and PAT Presentation
QbD and PAT Presentation
 
AMV final 20Jun17
AMV final 20Jun17AMV final 20Jun17
AMV final 20Jun17
 
Phase Appropriate Method Validation Aryo Boston-Nitto 2
Phase Appropriate Method Validation Aryo Boston-Nitto 2Phase Appropriate Method Validation Aryo Boston-Nitto 2
Phase Appropriate Method Validation Aryo Boston-Nitto 2
 
Analytical Method Validations & Detailed Method Validation Parameters
Analytical Method Validations & Detailed Method Validation ParametersAnalytical Method Validations & Detailed Method Validation Parameters
Analytical Method Validations & Detailed Method Validation Parameters
 
JPBA published-a platform aQbD approach for multiple methods development
JPBA published-a platform aQbD approach for multiple methods developmentJPBA published-a platform aQbD approach for multiple methods development
JPBA published-a platform aQbD approach for multiple methods development
 
App. Of Stat. Tools
App. Of Stat. ToolsApp. Of Stat. Tools
App. Of Stat. Tools
 
Points to Consider in QC Method Validation and Transfer for Biological Products
Points to Consider in QC Method Validation and Transfer for Biological ProductsPoints to Consider in QC Method Validation and Transfer for Biological Products
Points to Consider in QC Method Validation and Transfer for Biological Products
 
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
Measurement Systems Analysis - Variable Gage R&R Study Metrics, Applications ...
 
ISPE 2011 presentation Dagmar Meissner - 13Jan2011
ISPE 2011 presentation Dagmar Meissner - 13Jan2011ISPE 2011 presentation Dagmar Meissner - 13Jan2011
ISPE 2011 presentation Dagmar Meissner - 13Jan2011
 
Quality assurance part_2
Quality assurance part_2Quality assurance part_2
Quality assurance part_2
 
QM-026-Quality Management
QM-026-Quality ManagementQM-026-Quality Management
QM-026-Quality Management
 
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
Quality Control for Quantitative Tests by Prof Aamir Ijaz (Pakistan)
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
 
Process improvment
Process improvmentProcess improvment
Process improvment
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 

Analytical QBD -CPHI 25-27 July R00

  • 1. Analytical QBD in Nutshell Overview and Case Study….
  • 2. Agenda 2 What is AQBD ? 3 Case Study 1 Who we are ?
  • 4. Origin: Founded in 1999 in India by Mr. NC Narayanan Presence: Global footprint across 20+ Countries with headquarters in Mumbai, India Consulting Landscape: Business transformation across hundreds of industries including • Automobile • Pharma • FMCG • Life Science • Banking & Finance • Insurance • Plastics • Telecommunication • Packaging Contribution To The Industry: • Groomed over 5000 Business excellence professionals • Help transformed 100s of organizations worldwide • Enabled industries to provide best in class products and services • Contributed to sustainable economic development
  • 5. SSA Leadership Team Ganesh Iyer BE, MBA (INSEAD) MD SSA Tech Vijay Dhonde BE, CEO Sashi Iyer B.Com, MBA (INSEAD) MD SSA India NC BE, MS (Research) Chairman Naveen Narayanan BE, MBA (USA), MSc (UK) MD SSA Int
  • 6. SSA’s Pharma Offerings Pharma Excellence R & D Excellence QBD / DOE DFSS / NPI Lean CAPA Investigati on Manufacturing Excellence Lean Six Sigma CAPA Investigation Statistical Analysis for QA / QC
  • 11. Premium Training & Certification Lean Six Sigma Quality by Design DFSSCAPA Value Stream Mapping Problem Solving Tools ( 7 QC Tools ) Balanced Scorecard
  • 13. R & D EXCELLENCE - QUALITY BY DESIGN (QbD) - NPI LEAN
  • 14. Analytical Quality By Design (AQBD) Overview
  • 15. What is QBD ?  As per ICH, QbD is defined as “A systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management.”
  • 16. Analytical Target Profile (ATP) identification Identification includes the selection of method requirements such as target analytes, analytical technique category, and product specifications. Critical Quality Attributes (CQA) Identification Select appropriate analytical technique for desired measurement. Define method performance criteria ( critical Quality attributes) Risk Assessment using FMECA Assess risks of method operating parameters and sample variation. Method Development / Validation using DOE Examine potential multi-variate interactions. Understand method robustness and ruggedness Establish Control Strategy Define control space and system suitability, meet method performance criteria Continuous method monitoring and improvement CMM is final step in AQbD life cycle; it is a continuous process of sharing knowledge gained during development and implementation of design space AQbD ( Analytical QBD ) Roadmap
  • 17. What’s Needed QBD Approach Basics of Statistics Target measurement based on product QTPP and CQA Select Techniques for desired measurement Risk Assessment using FMECA Method Development / Validation using DOE Establish Control Strategy Continual Improvement
  • 19. Definition of Quality  ISO 9000 Definition of Quality: “Customer satisfaction” Statistical Definition of Quality: Q = f (Hitting the Target ,Reducing the variation)
  • 20. Measures Of Central Tendency  Numerical value that describes the central position of the data  Represent different ways of characterizing the central value of a collection of data.  Simply, it is the middle point of a distribution.  Also called as measures of location  Three of these measures are: • Mean • Median • Mode
  • 21. Measures Of Central Tendency  Let us take the following series :7,23,4,8,3,9,9 7+23+4+8+3+9+9 Mean = = 63/7=9 7 3 4 7 8 9 9 23 Median middle-most value Average Mode most repeated value (2 times)
  • 22. Curve B Curve C Curve A Mean of A,B,C Variation Measures Of Variation
  • 23. Measures Of Dispersion (Variation)  It is the spread or variability of the data set.  Three types of measures of dispersion are • Range • Variance and • Standard Deviation
  • 24. Range  It is the difference between the highest and lowest observed values  Range = Value of Highest observation - Value of Lowest observation Example:  Let us take the following series 3,6,4,9,5,6,7,1,6,3,2,9,8,6,4,2. Max Value = 9 Min Value = 1 Range= 9 -1=8
  • 25. Observations (x1,x2..xn) n - total no. of observations Mean ( µ ) ( i - observed item) Deviation di = Xi- µ * * * * * * * * * * * * * * * * * * * * * * * * * variable frequency d1 d2 d3 d4 d5 Variance And Standard Deviation
  • 26. Null Hypothesis (H0) : The hypothesis to be tested, usually an assumption of status quo (equality, i.e.. no difference). No Significant impact on CQA / Response ( P > 0.050 ) Alternate Hypothesis (Ha) : The condition of equality assumed in the Null hypothesis is not true. There is a Significant impact on CQA / Response( P < 0.05) USE ANOVA ( Analysis of Variance ) for analysis Types of Hypothesis
  • 27. Hypothesis Testing  Statistical Hypothesis: There is no difference between the old machines and the improved one.  This is called the Null Hypothesis (Ho) • Real Life Hypothesis: The newly modified machine will reduce defects. • This is called the Alternative Hypothesis (Ha) Ho: Ha: a a m m m m = < b b • We must show that the values we observed were so unlikely to come from the same process, that Ho must be wrong.
  • 28. X (Input) y (Output) • Tells the relationship between the two variables X and Y • X is the input variable on x(horizontal)-axis • Y is the output variable on the Y(vertical)-axis Use R-Sq Value for Model Significance Correlation & Regression Analysis
  • 30. Project Scenario To optimise Related Substance Method that is Specific, Selective, Reproducible and Robust and is acceptable to the plant and regulatory agencies. This project is due for technology transfer at the manufacturing location. • To develop the robust and reproducible method for the quantification of Unknown impurity eluting at the tail of XYZ Peak with USP Resolution of NLT 3.5 between main peak and unknown impurity along with resolution of all other known impurities. – Resolution – Retention time
  • 31. Analytical Target Profile (ATP) • General ATP for analytical procedures is as follows: – Target analytes selection (API and impurities) • ICH Q3 and all other regulatory guidance explained the consideration of impurities in the API synthetic route – Technique selection (HPLC, GC, HPTLC, Ion Chromatography, chiral HPLC, etc.) • Analytical test item and purpose of test are also important for selecting the technique – Method requirements selection (assay or impurity profile or residual solvents) • Method requirements can vary from one method to another. The common ATPs for impurity profile by HPLC method
  • 32. Critical Quality Attributes (CQA) CQA for analytical methods includes method attributes and method parameters. Each analytical technique has different CQA. • HPLC (UV or RID) CQA are mobile phase buffer, pH, diluent, column selection, organic modifier, and elution method. • GC methods CQA are gas flow, oven temperature and program, injection temperature, sample diluent, and concentration. • HPTLC method CQA are TLC plate, mobile phase, injection concentration and volume, plate development time, color development reagent, and detection method Note : Nature of impurities and DS can define the CQA for analytical method development such as solubility, pH value, polarity, charged functional groups, boiling point, and solution stability
  • 34. Mapping the Linkage : Method attributes and Method Parameters M1 M2 Method Attributes P1 P2 Method Parameters P3 CQA1 CQA2 Critical Quality Attributes CQA3 P2 might not be needed in the establishment of Design Space Source: CDER & FDA Purpose: Understand & Control the variability of Method Attributes & Critical method Parameters to meet CQA’s
  • 35. Qualitative Risk Assessment Criteria Red Color High Risks Risks that need to be addressed by actual studies to establish acceptable ranges Yellow Color Medium Risks Possibility for a change in factor level to affect method robustness but small variations in this factor do not adversely affect pharmaceutical quality Green Color Low risks Factors having wide range of acceptability • Risk estimation helps to identify what to study as a part of analytical method development • Evaluation of qualitative risk is ultimately linked back to potential harm to the patient
  • 36. Qualitative Risk Assessment : Prioritization Matrix Attributes Resolution Justification Column type Kept constant Column make Kept constant Particle size of the column has impact on Resolution Column length has impact on Resolution % Carbon loading Column make is constant so % Carbon loading is constant Internal diameter of column Kept constant Mobile phase buffer Kept constant (potassium dihydrogen phosphate) Modifier used in Buffer and its qty has impact on Resolution Mobile phase composition has impact on Resolution as polarity of solvents are diff System make No impact on resolution Detector sensitivity (UV/PDA) This impacts the Limit of detection and quantitation but will have no impact on resolution
  • 37. Qualitative Risk Assessment : Prioritization Matrix Attributes Resolution Justification UV Lamp hours This impacts the Limit of detection and quantitation but will have no impact on resolution Type of elution (Gradient/ Isocratic) Kept constant (Gradient) Make of reagents Kept constant Different lots of Drug Product tested Kept constant Analyst Constant Column temperature Column temperature influences the resolution between peaks Flow rate of system Flow rate changes the retention time but this may or may not impact resolution pH of the mobile phase buffer Has impact on Resolution as different peaks will have different retention time at diff pH due to their pKa values Detection wavelength Kept constant at 240 nm Lot number of the column Kept constant Sample preparation technique (Intact/crushed) Kept constant Organic used in Mobile phase has impact on Resolution as polarity of solvents are diff
  • 39. FMECA – Identify critical factors  To study the critical factors, the team conducted a risk assessment using a FMECA.  Output from the risk assessment study was based on risk score which was used to identify the critical factors required for the study  Risk priority scores included an estimate for detectability, severity and probability
  • 40. Severity Scores Rating Score Severity Description of impact on patient if failure to meet acceptance criteria 1 Minor No impact on patient 2 Major Some impact on product, but reversible 3 Critical Impact on product but not product life threatening (rejection) 4 Catastrophic High impact on product which is irreversible and potentially wastage Probability Scores Rating Score Probability of not meeting acceptance Comment 1 Extremely low Extremely low chance of occurring, never seen 2 Low Low chance of occurring, but could happen 3 Medium Will happen 4 High High occurrence of failure
  • 41. Detectability Scores Rating Score Detectability scores Comment 1 Very high Failure can be detected in unit operation 2 High Failure can be detected after unit operation and before end product testing 3 Low Will happen 4 None High occurrence of failure Risk Score Risk priority number range Risk rating 1 to 17 Low 18 to 35 Medium 36 to 64 High RPN scores were grouped into high, medium, and low risk. The boundaries for differentiation between high, medium, and low were established by the risk assessment team for this exercise.
  • 42. Quantitative Risk Assessment: FMECA Process Parameter or Material Attribute Effect/ Suggested contingency/ Comment Probability (P) Severity (S) Control (C) RPN Risk Rating Column temperature Justification 4 3 2 24 Medium Flow rate of system To be studied 2 2 2 8 Low Detector sensitivity (UV/PDA) To be kept constant at 1 mL/minute 2 2 1 4 Low Column make Kept Constant UV Detector of All-15 4 2 1 8 Low Particle size of the column based on earlier expts the make giving best resolution is selected and is kept constant 4 4 3 48 High Mobile phase composition (aqueous and organic) To be studied for the impact of change in micron over resolution 4 4 3 48 High Modifier used in Buffer and its qty decided to keep the composition as constant and vary the type of organic (Gradient program is constant) 3 3 2 18 Medium Type of organic used in Mobile phase In this case no modifier used 4 4 3 48 High pH of the mobile phase buffer to be studied for ACN and methanol 4 4 3 48 High Column length To be studied 4 4 3 48 High
  • 43. Response ( CQA ) Response Unit Target Comment Resolution Numbers NLT 3.5 Retention time Mins NMT 75 Analysis needs to be completed before 75 mins else the impurity is not detected
  • 44. Experimental Factors Experimental Factor Unit Low Level High Level Comments/ Remarks Column temperature deg C 25 45 Currently selected column temperature is 30 deg C and lower range selected at room temp and higher range at 45 deg is within the cut off temperature of 60 deg C Particle size of the column micron 3 5 Particle size impacts separation, lower & higher values selected based on the availability Column length cm 150 250 Column length impacts separation, lower & higher values selected based on the availability Acetonitrial % 50 100 100% Methanol not selected as this may increase the back pressure and may go beyond operating range for 3µ column pH of the mobile phase buffer 2 7 Current pH of the mobile phase is 3.5 and range is selected based on the optimum operating range of the column
  • 45. Constant Factors Constant Factors Unit Level System make HPLC Alliance -15 UV Lamp hours Hours Same instrument will be used so this will remain constant throughout Calibration of the HPLC Yes Calibrated instrument will be used Volume of Mobile phase prepared mL 1000 mL (same qty of mobile phase will be prepared each set) Analyst Sandeep Gawas % Carbon loading 15% Age of the column New Column will be used for study and same will be used for all expt except for the change in column Column type Inertsil ODS 3 L1 Different lots of Drug Product tested Batch No. A-12 Internal diameter of column mm 4.6 mm Lot number of the column Make of reagents AR Grade Merck and same Lot No. from one bottle will be used Water Quality HPLC Grade TKA of fourth floor Age of the sample 3 Month old sample CRT sample
  • 46. Constant Factors Constant Factors Unit Level Column Equilibriation time Hour 1 Hour before the injection acquisition Detection wavelength nm Fixed at 240 nm Injection volume µL Fixed at 20µL Type of elution (Gradient/ Isocratic) Gradient program fixed Previous use of the column (Product/washing solvent) New column to be used for the expt Mobile phase buffer potassium dihydrogen orthophosphate 1.36 gm/L Type of filter used for Mobile Phase filtration Millipore 0.45 µ Order of addition of diluent Fixed as per STP Sample concentration ppm Fixed at 600 ppm as per STP Sample preparation technique (Intact/crushed) Crushed Method to be followed as per STP Sample solution stability Days Same Sample preparation to be used for 8 Days Sampling (Representative sample) Sample to be used from single container at the start of expt Room temperature and Humidity deg C & % RH 25+/- 5 deg and 65+/-5% RH Storage of the samples In Laboratory pH meter A197 Balance used A200 Cylinder used for Volume measurement Class A Same Cylinder to be used through out the expt Sonnicator A199 Sample preparation Filter 0.45 µ Make MDI, discard volume 1 mL
  • 47. Design Selection Matrix Parameter Fractional Factorial Half Fraction Full Factorial Mixture RSM Type of design Screening Basic Basic Basic + Optimization Optimization No. of Responses 1-2 1-2 1-3 2-3 2 or more Factors More than 5 4-5 3-4 3-4 3-4 Expected outcome • Identify significant factors with main effect only • Eliminate insignificant factors for next level of experiment • Identify the main effects & interaction effect • Get prediction equation • Curvature with 1 center point • Identify the main effects & interaction effect • Get prediction equation • Curvature with 1 center point • Identify design space • Identify the main effects & interaction effect • Optimum proportion for mixture • Get prediction equation • Identify design space • Identify right factor settings for optimum operation • Identify design space Pre-requisite None None • None •Composition type •Quantitative All should be quantitative Additional elements None • Include center point to check curvature • Include center point to check curvature • Augmentation done to get precise results • None
  • 48. Screening Design : Resolution V Std Order Run Order Center Pt Block Column temp Particle Size % Acetonitrile Column Length pH of MP Resolution Retention Time 11 1 1 2 25 5 50 150 7 6.20 75.626 9 2 1 2 25 3 50 250 7 9.60 58.120 10 3 1 2 45 3 50 150 2 2.93 71.112 12 4 1 2 45 5 50 250 2 3.25 72.119 15 5 1 2 25 5 100 150 2 2.91 62.875 14 6 1 2 45 3 100 150 7 7.57 58.276 13 7 1 2 25 3 100 250 2 3.48 49.501 16 8 1 2 45 5 100 250 7 6.92 57.980 2 9 1 1 45 3 50 150 2 2.88 58.243 6 10 1 1 45 3 100 150 7 6.79 49.321 8 11 1 1 45 5 100 250 7 6.35 62.924 3 12 1 1 25 5 50 150 7 6.44 70.626 7 14 1 1 25 5 100 150 2 2.80 58.150 4 15 1 1 45 5 50 250 2 3.09 75.721 5 16 1 1 25 3 100 250 2 3.35 72.035
  • 49. Residual Analysis : Sanity check of Experimental Trials As seen from the residual above, the residuals are normally distributed, with random variation and within the limits of +/-2%. Hence, it can be concluded that the experimental error is minimum
  • 50. Initial results For Resolution: ANOVA R-Sq = 99.59% R-Sq(pred) = 97.87% R-Sq(adj) = 99.13% Analysis of Variance for Resolution (coded units) Source DF Seq SS Adj SS Adj MS F P Blocks 1 0.2233 0.2233 0.2233 4.40 0.074 Main Effects 5 82.868 82.868 16.5736 326.63 0.000 Column temperatu 1 1.1396 1.1396 1.1396 22.46 0.002 Particle size of 1 3.9105 3.9105 3.9105 77.07 0.000 %Acetonitrile 1 0.7613 0.7613 0.7613 15.00 0.006 Column length 1 2.8815 2.8815 2.8815 56.79 0.000 pH of the mobile 1 74.1752 74.1752 74.1752 1461.81 0.000 2-Way Interactions 2 3.5921 3.5921 1.796 35.40 0.000 Particle size of the column*%Acetonitrile 1 0.7613 0.7613 0.7613 15.00 0.006 Particle size of the column*pH of the mobile phase buffer 1 2.8308 2.8308 2.8308 55.79 0.000 Residual Error 7 0.3552 0.3552 0.0507 Total 15 87.0385 0.2233 0.2233 P Value for Linear , Interaction term is less than 0.05 hence very significant
  • 51. R-Sq = 99.99% R-Sq(pred) = 99.95% R-Sq(adj) = 99.98% Analysis of Variance for Retention Time (coded units) Source DF Seq SS Adj SS Adj MS Blocks 1 0.03 0.026 0.076 Main Effects 4 1049.66 880.170 220.043 Column temperature 1 104.15 214.096 214.096 Particle size of the column 1 131.45 8.492 8.492 %Acetonitrile 1 195.16 307.751 307.751 Column length 1 618.90 500.927 500.927 2-Way Interactions 1 10.37 10.373 10.373 Particle size of the column*%Acetonitrile 1 10.37 10.373 10.373 Residual Error 7 0.14 0.140 0.020 Total 13 1060.20 Source F P Blocks 1.33 0.287 Main Effects 11040.61 0.000 Column temperature 10742.26 0.000 Particle size of the column 426.08 0.000 %Acetonitrile 15441.38 0.000 Column length 25133.95 0.000 2-Way Interactions 520.45 0.000 Particle size of the column*%Acetonitrile 520.45 0.000 Residual Error Total Initial Result For Retention Time: ANOVA P Value for Linear , Interaction term is less than 0.05 hence very significant
  • 52. Why RSM  Most surfaces are flatter further away from optimal settings. • Use linear models when we are far from the optimums. • Use quadratics to approximate the surfaces near the peaks Curved line represents the response better as compared to the straight line
  • 53. R00 0512  Response Surface Methodology uses a quadratic model (that includes the squared term).  For one X the equation is:  This model produces parabolas such as: The Quadratic Model : Curvature 2 1 2y a b x b x=  
  • 54. Result Summary for Resolution and Retention Time • Based on the results for Resolution & Retention Time and considering that no terms have been dropped for Resolution, it was decided to add 2 more trials with centre point setting. It would help in analysing the response better as well and identify the curvature if present in the design. Since column length is a discrete factor and in future it would be advisable to use the column length at 150, it was decided to set it as constant. Also, based on team’s domain knowledge and expertise particle size was set at 5 micron. • Settings for centre points run are: – Column Length – 150 (constant) – Particle Size – 5 micron (constant) – pH of mobile phase – 4.5 (center) – Column temperature – 35 Deg (center) – % Acetronitrile – 75% (center
  • 55. Experiments with Centre Points Std Order Run Order Center Pt Bloc k Colum n temp Particl e Size % Acetonitril e Column Length pH of MP Resolution Retentio n Time 11 1 1 2 25 5 50 150 7 6.20 75.626 9 2 1 2 25 3 50 250 7 9.60 58.120 10 3 1 2 45 3 50 150 2 2.93 71.112 12 4 1 2 45 5 50 250 2 3.25 72.119 15 5 1 2 25 5 100 150 2 2.91 62.875 14 6 1 2 45 3 100 150 7 7.57 58.276 13 7 1 2 25 3 100 250 2 3.48 49.501 16 8 1 2 45 5 100 250 7 6.92 57.980 2 9 1 1 45 3 50 150 2 2.88 58.243 6 10 1 1 45 3 100 150 7 6.79 49.321 8 11 1 1 45 5 100 250 7 6.35 62.924 3 12 1 1 25 5 50 150 7 6.44 70.626 7 14 1 1 25 5 100 150 2 2.80 58.150 4 15 1 1 45 5 50 250 2 3.09 75.721 5 16 1 1 25 3 100 250 2 3.35 72.035 17 17 0 1 35 5 75 150 4.5 2.70 57.980 18 18 0 1 35 5 75 150 4.5 2.60 56.900
  • 56. Resolution analysis with centre point :Anova Analysis: Resolution Figure below shows the results of centre point analysis conducted on the experiment results for Resolution R-Sq = 96.01% R-Sq(pred) = 78.73% R-Sq(adj) = 93.21% Analysis of Variance for Resolution (coded units) Source DF Seq SS Adj SS Adj MS F P Blocks 1 2.3717 0.2233 0.2233 0.56 0.470 Main Effects 5 89.4256 82.8680 16.5736 41.93 0.000 Column temperature 1 1.1396 1.1396 1.1396 2.88 0.120 Particle size of the column 1 7.9974 3.9105 3.9105 9.89 0.010 %Acetonitrile 1 0.7613 0.7613 0.7613 1.93 0.195 Column length 1 5.3522 2.8815 2.8815 7.29 0.022 pH of the mobile phase buffer 1 74.1752 74.1752 74.1752 187.68 0.000 Curvature 1 3.2137 3.2137 3.2137 8.13 0.017 Residual Error 10 3.9523 3.9523 0.3952 Lack of Fit 9 3.9473 3.9473 0.4386 87.72 0.083 Pure Error 1 0.0050 0.0050 0.0050 Total 17 98.9632
  • 57. Prioritized Terms for Resolution Based on the results from the above analysis, it can be clearly seen that:  Curvature effect is present which urges for a RSM model to predict the response  The factors identified as significant are: pH of mobile phase, Particle size, and Column length
  • 58. Analysis: Retention Time S = 1.04461 PRESS = 45.2842 R-Sq = 99.23% R-Sq(pred) = 96.01% R-Sq(adj) = 98.56% Analysis of Variance for rt of Imp A (coded units) Source DF Seq SS Adj SS Adj MS F P Blocks 1 9.02 0.03 0.026 0.02 0.880 Main Effects 5 1110.61 1052.03 210.406 192.82 0.000 Column temperature 1 96.22 263.03 263.032 241.04 0.000 Particle size of the column 1 75.81 1.76 1.763 1.62 0.239 %Acetonitrile 1 195.16 365.92 365.922 335.33 0.000 Column length 1 740.11 574.45 574.448 526.43 0.000 pH of the mobile phase buffer 1 3.31 2.37 2.366 2.17 0.179 Curvature 1 5.54 5.54 5.537 5.07 0.054 Residual Error 8 8.73 8.73 1.091 Lack of Fit 7 8.15 8.15 1.164 2.00 0.498 Pure Error 1 0.58 0.58 0.583 Total 15 1133.89 Retention Time with centre point :Anova
  • 59. Particle size of the column pH of the mobile phase buffer Column temperature %Acetonitrile Column length 2520151050 Term Standardized Effect 2.31 Pareto Chart of the Standardized Effects (response is rt of Imp A, Alpha = 0.05) Based on the results from the above ANOVA table and Pareto Chart, we can conclude  Curvature effect is present for this response  The factors identified as significant are: Column length, % Acetonitrile, and Column temperature Prioritized Terms for Retention Time
  • 60. Significant Factors • Out of the five factors selected for the screening design, the factors that are significant are: • After discussion and analysis with the team, it was decided that the following factors will be selected for optimization design: – Column length (Experimental): Axial Low (150), Axial High (250) – Column Temperature: Axial Low (25), Axial High (45) – pH: Axial Low (2), Axial High (7) – %ACN: Axial Low (100), Axial High (100) – Particle Size (Constant): 5 micron • A 30 trial Central Composite design has been suggested for optimization Response 1 - Resolution Response 2 – Retention time pH Column temperature particle size %ACN column length Column length
  • 61. Optimized RSM Design Std Run Type Col Temp %ACN pH Column Length Resolution Retention Time 1 8 Factorial 29 60 3.0 150 2.57 65.572 2 18 Factorial 41 60 3.0 150 2.55 58.917 3 27 Factorial 29 90 3.0 150 2.51 58.510 4 9 Factorial 41 90 3.0 150 2.42 53.262 5 2 Factorial 29 60 6.0 150 3.60 65.751 6 28 Factorial 41 60 6.0 150 4.42 59.190 7 4 Factorial 29 90 6.0 150 3.79 58.690 8 13 Factorial 41 90 6.0 150 3.94 53.067 9 25 Axial 25 75 4.5 150 2.55 64.070 10 19 Axial 45 75 4.5 150 2.57 54.288 11 26 Axial 35 50 4.5 150 2.54 64.877 12 29 Axial 35 100 4.5 150 2.49 53.880 13 15 Axial 35 75 2.0 150 4.95 58.822 14 6 Axial 35 75 7.0 150 5.27 58.718 15 12 Center 35 75 4.5 150 2.48 58.849 17 17 Factorial 41 60 3.0 250 3.07 74.916 18 22 Factorial 29 90 3.0 250 3.13 73.542 19 3 Factorial 41 90 3.0 250 3.03 66.358 21 16 Factorial 41 60 6.0 250 6.02 75.060 22 20 Factorial 29 90 6.0 250 4.02 73.522 23 5 Factorial 41 90 6.0 250 5.62 66.799 24 1 Axial 25 75 4.5 250 3.11 82.293 25 24 Axial 45 75 4.5 250 3.08 67.955 27 7 Axial 35 100 4.5 250 3.20 67.102 28 30 Axial 35 75 2.0 250 3.29 74.211 29 23 Axial 35 75 7.0 250 6.29 74.483 30 14 Center 35 75 4.5 250 2.24 74.311
  • 62. Final Model for Resolution : ANOVA Reduced Model (Resolution) S = 0.453124 PRESS = 9.91394 R-Sq = 88.33% R-Sq(pred) = 74.40% R-Sq(adj) = 84.62% Analysis of Variance for Resolution Source DF Seq SS Adj SS Adj MS F P Regression 7 34.2053 34.2053 4.8865 23.80 0.000 Linear 4 17.0199 17.0199 4.2550 20.72 0.000 Col Temp 1 0.4272 0.4272 0.4272 2.08 0.163 %ACN 1 0.1285 0.1285 0.1285 0.63 0.437 pH 1 13.9586 13.9586 13.9586 67.98 0.000 Column Length 1 2.5056 2.5056 2.5056 12.20 0.002 Square 1 14.4146 14.4146 14.4146 70.20 0.000 pH*pH 1 14.4146 14.4146 14.4146 70.20 0.000 Interaction 2 2.7707 2.7707 1.3854 6.75 0.005 Col Temp*pH 1 0.9702 0.9702 0.9702 4.73 0.041 pH*Column Length 1 1.8005 1.8005 1.8005 8.77 0.007 Residual Error 22 4.5171 4.5171 0.2053 Total 29 38.7223
  • 63. Resolution : Model Interpretation As per the ANOVA table above, it can be seen that: – The squared term pH is significant for resolution – There is an interaction between Column temp & pH, and Column length & pH – The R-Sq values are 88.83% which determines that the model is good for prediction of the response
  • 64. Reduced Model (Retention Time) S = 0.221488 PRESS = 3.08824 R-Sq = 99.95% R-Sq(pred) = 99.82% R-Sq(adj) = 99.93% Analysis of Variance for Retention Time Source DF Seq SS Adj SS Adj MS F P Regression 9 1711.39 1711.39 190.15 3876.21 0.000 Linear 4 1697.67 1351.38 337.84 6886.80 0.000 Col Temp 1 136.47 277.18 277.18 5650.10 0.000 %ACN 1 98.11 245.63 245.63 5007.11 0.000 pH 1 0.07 0.07 0.07 1.33 0.264 Column Length 1 1463.02 1273.40 1273.40 25957.74 0.000 Square 2 1.04 1.15 0.58 11.75 0.001 Col Temp*Col Temp 1 0.98 0.81 0.81 16.54 0.001 %ACN*%ACN 1 0.06 0.70 0.70 14.32 0.001 Interaction 3 12.68 12.68 4.23 86.17 0.000 Col Temp*%ACN 1 0.04 2.02 2.02 41.19 0.000 Col Temp*Column Length 1 4.15 7.35 7.35 149.86 0.000 %ACN*Column Length 1 8.49 8.49 8.49 173.02 0.000 Residual Error 17 0.83 0.83 0.05 Total 26 1712.22 Final Model for Retention Time : ANOVA
  • 65. As seen from the ANOVA tables above, it can be concluded that: – There is a squared effect of Column Temperature and % Acetonitrile on the response – Interaction exists between Column Temperature & %ACN, Column Temp & Column Length, and %ACN & Column Length – Also, the R-Sq value of the reduced model is 99.95% which is in indicator that the predictability of the model will be very good Retention Time : Model Interpretation
  • 66. Optimum Settings For Validation • Parameters Goal Lower Target Upper • Resolution Maximum 4 6 6 • Retention Ti Minimum 55 55 75 • Optimum settings – Col Temp = 45 – %ACN = 100 – pH = 6.6 – Column Lengt = 150 • Predicted Responses – Resolution = 5.0123 – Retention Ti = 52.2091
  • 67. Optimization Settings Cur High Low0.71144 D New d = 0.50614 Maximum Resoluti y = 5.0123 d = 1.0000 Minimum Retentio y = 52.2091 0.71144 Desirability Composite 150.0 250.0 2.0 7.0 50.0 100.0 25.0 45.0 %ACN pH Column LCol Temp [40.0] [100.0] [6.60] [150.0]
  • 68. Validation Trials • Validation runs were conducted to test the settings identified using DOE. The results after validation run were as follows: Date Analyst LNB Ref Resolution Rt of Impurity A 30-12-2013 Sandeep SL1030-71 5.32 59.733 01-01-2014 Varsha SL1030-73 5.52 59.781 02-01-2014 Varsha SL1030-75 5.60 59.849
  • 69. Design Space • The desired profile for both the responses are: – Response Goal Lower Target Upper – Resolution Maximum 4 6 6 – Retention Ti Minimum 55 55 75
  • 70. Design Space • Based on the above desired response values, the design space is identified as below Design Space Design Space The design space for both the parameters (highlighted in yellow in the above figure) has been identified which is as given below  %ACN – 50 to 70  Column length – 150 constant as it is a discrete factor  Column temperature – 35 to 45  pH value – 6.2 to 6.8